Clinical Trials Update: Nov. 19, 2003
Ulcerative Colitis Diabetic Foot Ulcers Non-Hodgkin's Lymphoma
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study to assess the safety and efficacy of an investigational drug in patients with moderate to severe ulcerative colitis (UC). Volunteers 12 and older who have evidence of active UC and have been diagnosed with UC for at least 4 months may be eligible. Research sites located throughout the United States.
Diabetic Foot Ulcers
A study to learn more about the safety of an investigational topical gel for the treatment of diabetic foot ulcers. Volunteers 18 or older who have Type 1 or Type 2 diabetes and who have an open sore on his/her foot may be eligible. Research site located in San Diego, Ca.
A study of an investigational medication for patients with relapsed or refractory non-Hodgkin's lymphoma. Volunteers at least 18 who have been diagnosed with CD20+, relapsed or refractory non-Hodgkin's lymphoma (including chronic lymphocytic leukemia) and who have normal organ function test results may be eligible. Research site located in Gainesville, Fla.
Copyright 2003 CenterWatch. All rights reserved.